A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Quality assured implementation of the Slovenian breast cancer screening programme




TekijätJarm Katja, Kadivec Maksimiljan, Šval Cveto, Hertl Kristijana, Žakelj Maja Primic, Dean Peter B., von Karsa Lawrence, Žgajnar Janez, Gazić Barbara, Kutnar Veronika, Zdešar Urban, Borovčić Mateja Kurir, Zadnik Vesna, Josipović Igor, Krajc Mateja

KustantajaPublic Library of Science

Julkaisuvuosi2021

JournalPLoS ONE

Tietokannassa oleva lehden nimiPLoS ONE

Artikkelin numeroe0258343

Vuosikerta16

Numero44479

eISSN1932-6203

DOIhttps://doi.org/10.1371/journal.pone.0258343

Verkko-osoitehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0258343

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/67674374


Tiivistelmä

Setting

The organised, population-based breast cancer screening programme in Slovenia began providing biennial mammography screening for women aged 50–69 in 2008. The programme has taken a comprehensive approach to quality assurance as recommended by the European guidelines for quality assurance in breast cancer screening and diagnosis (4th edition), including centralized assessment, training and supervision, and proactive monitoring of performance indicators. This report describes the progress of implementation and rollout from 2003 through 2019.

Methods

The screening protocol and key quality assurance procedures initiated during the planning from 2003 and rollout from 2008 of the screening programme, including training of the professional staff, are described. The organisational structure, gradual geographical rollout, and coverage by invitation and examination are presented.

Results

The nationwide programme was up and running in all screening regions by the end of 2017, at which time the nationwide coverage by invitation and examination had reached 70% and 50%, respectively. Nationwide rollout of the population-based programme was complete by the end of 2019. By this time, coverage by invitation and examination had reached 98% and 76%, respectively. The participation rates consistently exceeded 70% from 2014 to 2019.

Conclusions

The successful implementation of the screening programme can be attributed to an independent central management, external guidance, and strict adherence to quality assurance procedures, all of which contributed to increasing governmental and popular support. The benefits of quality assurance have influenced all aspects of breast care and have provided a successful model for multidisciplinary management of other diseases.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 19:58